kwic
further
further
right
off
ON
277
1
100
500
strict
ELIZA cgi-bash version rev. 1.91
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for further out of >500 occurrences
298283 occurrences (No.79 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to further]
298283 occurrences (No.79 in the rank) during 5 years in the PubMed. [cache]
| 277) Efficacy is further enhanced by cancer cell sensitization using aminobisphosphonates or Ara-C. |
| PMID:35028614 DOI:10.1016/j.xcrm.2021.100473 |
| 2021 Cell reports. Medicine |
| * TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer. |
| - Despite its role in cancer surveillance, adoptive immunotherapy using γδ T cells has achieved limited efficacy. To enhance trafficking to bone marrow, circulating Vγ9Vδ2 T cells are expanded in serum-free medium containing TGF-β1 and IL-2 (γδ[T2] cells) or medium containing IL-2 alone (γδ[2] cells, as the control). Unexpectedly, the yield and viability of γδ[T2] cells are also increased by TGF-β1, when compared to γδ[2] controls. γδ[T2] cells are less differentiated and yet display increased cytolytic activity, cytokine release, and antitumor activity in several leukemic and solid tumor models. Efficacy is further enhanced by cancer cell sensitization using aminobisphosphonates or Ara-C. A number of contributory effects of TGF-β are described, including prostaglandin E2 receptor downmodulation, TGF-β insensitivity, and upregulated integrin activity. Biological relevance is supported by the identification of a favorable γδ[T2] signature in acute myeloid leukemia (AML). Given their enhanced therapeutic activity and compatibility with allogeneic use, γδ[T2] cells warrant evaluation in cancer immunotherapy. |
[
right
kwic]
(1)83  research |
(16)4 validation |
(31)2 and |
(46)2 high-quality |
| (2)43 studies |
(17)3 confirmed |
(32)2 attention |
(47)2 inform |
| (3)22 investigation |
(18)3 demonstrate |
(33)2 characterization |
(48)2 insight |
| (4)9 analysis |
(19)3 demonstrated |
(34)2 clinical |
(49)2 reduce |
| (5)9 study |
(20)3 highlight |
(35)2 considerations |
(50)2 research, |
| (6)7 the |
(21)3 identify |
(36)2 develop |
(51)2 screening |
| (7)7 work |
(22)3 in |
(37)2 developing |
(52)2 showed |
| (8)5 development |
(23)3 investigated |
(38)2 discussion |
(53)2 structure-based |
| (9)5 evidence |
(24)3 investigations |
(39)2 divided |
(54)2 studied |
| (10)4 evaluate |
(25)3 literature |
(40)2 enhanced |
(55)2 supported |
| (11)4 evaluation |
(26)3 our |
(41)2 evaluated |
(56)2 tested |
| (12)4 exploration |
(27)3 show |
(42)2 evaluations |
(57)2 this |
| (13)4 explore |
(28)3 we |
(43)2 examined |
(58)2 understand |
| (14)4 improve |
(29)2 aid |
(44)2 explored |
(59)2 understanding |
| (15)4 investigate |
(30)2 analyses |
(45)2 extend |
add keyword
--- WordNet output for further ---